Castle Common Stock Total Equity from 2010 to 2024
| CSTL Stock | USD 23.15 0.12 0.52% |
Common Stock Total Equity | First Reported 2010-12-31 | Previous Quarter 28.8 K | Current Value 30.2 K | Quarterly Volatility 12.1 K |
Check Castle Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Castle Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 125 K, Net Interest Income of 10.3 M or Interest Income of 10.3 M, as well as many indicators such as Price To Sales Ratio of 2.5, Dividend Yield of 0.0 or PTB Ratio of 1.55. Castle financial statements analysis is a perfect complement when working with Castle Biosciences Valuation or Volatility modules.
Castle | Common Stock Total Equity |
Latest Castle Biosciences' Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Castle Biosciences over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Castle Biosciences' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Castle Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Castle Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 11,201 | |
| Geometric Mean | 5,303 | |
| Coefficient Of Variation | 108.09 | |
| Mean Deviation | 11,164 | |
| Median | 1,896 | |
| Standard Deviation | 12,107 | |
| Sample Variance | 146.6M | |
| Range | 28.3K | |
| R-Value | 0.88 | |
| Mean Square Error | 35.8M | |
| R-Squared | 0.77 | |
| Significance | 0.000016 | |
| Slope | 2,381 | |
| Total Sum of Squares | 2.1B |
Castle Common Stock Total Equity History
About Castle Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Castle Biosciences income statement, its balance sheet, and the statement of cash flows. Castle Biosciences investors use historical funamental indicators, such as Castle Biosciences's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Castle Biosciences investors may use each financial statement separately, they are all related. The changes in Castle Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Castle Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Castle Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Castle Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 28.8 K | 30.2 K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Castle Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Castle Stock
When determining whether Castle Biosciences is a strong investment it is important to analyze Castle Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Castle Biosciences' future performance. For an informed investment choice regarding Castle Stock, refer to the following important reports:Check out the analysis of Castle Biosciences Correlation against competitors. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (1.13) | Revenue Per Share 9.279 | Quarterly Revenue Growth 0.736 | Return On Assets (0.06) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.